AAAAAA
Results:
1-8
|
Results: 8
Authors:
KOLLARITSCH H
FURER E
HERZOG C
WIEDERMANN G
QUE JU
CRYZ SJ
Citation: H. Kollaritsch et al., RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF COMBINED SALMONELLA-TYPHI TY21A AND VIBRIO-CHOLERAE-CVD 103-HGR LIVE ORAL VACCINES, Infection and immunity, 64(4), 1996, pp. 1454-1457
Authors:
RUBINSTEIN A
GOLDSTEIN H
PETTOELLOMANTOVANI M
MIZRACHI Y
BLOOM BR
FURER E
ALTHAUS B
QUE JU
HASLER T
CRYZ SJ
Citation: A. Rubinstein et al., SAFETY AND IMMUNOGENICITY OF A V3 LOOP SYNTHETIC PEPTIDE CONJUGATED TO PURIFIED PROTEIN DERIVATIVE IN HIV-SERONEGATIVE VOLUNTEERS, AIDS, 9(3), 1995, pp. 243-251
Authors:
CRYZ SJ
QUE JO
CROSS AS
FURER E
Citation: Sj. Cryz et al., SYNTHESIS AND CHARACTERIZATION OF A POLYVALENT ESCHERICHIA-COLI O-POLYSACCHARIDE TOXIN-A CONJUGATE VACCINE, Vaccine, 13(5), 1995, pp. 449-453
Authors:
CRYZ SJ
GOLDSTEIN H
PETTOELLOMANTOVANI M
KIM A
FURER E
QUE JU
HASLER T
RUBINSTEIN A
Citation: Sj. Cryz et al., HUMAN-IMMUNODEFICIENCY-VIRUS-1 PRINCIPAL NEUTRALIZING DOMAIN PEPTIDE-TOXIN-A CONJUGATE VACCINE, Vaccine, 13(1), 1995, pp. 67-71
Authors:
LANG AB
SCHAAD UB
RUDEBERG A
WEDGEWOOD J
QUE JU
FURER E
CRYZ S
Citation: Ab. Lang et al., EFFECT OF HIGH-AFFINITY ANTIPSEUDOMONAS AERUGINOSA LIPOPOLYSACCHARIDEANTIBODIES INDUCED IMMUNIZATION ON THE RATE OF PSEUDOMONAS-AERUGINOSAINFECTION IN PATIENTS WITH CYSTIC-FIBROSIS, The Journal of pediatrics, 127(5), 1995, pp. 711-717
Authors:
CROSS A
ARTENSTEIN A
QUE J
FREDEKING T
FURER E
SADOFF JC
CRYZ SJ
Citation: A. Cross et al., SAFETY AND IMMUNOGENICITY OF A POLYVALENT ESCHERICHIA-COLI VACCINE INHUMAN VOLUNTEERS, The Journal of infectious diseases, 170(4), 1994, pp. 834-840
Authors:
CRYZ SJ
WEDGWOOD J
LANG AB
RUEDEBERG A
QUE JU
FURER E
SCHAAD UB
Citation: Sj. Cryz et al., IMMUNIZATION OF NONCOLONIZED CYSTIC-FIBROSIS PATIENTS AGAINST PSEUDOMONAS-AERUGINOSA, The Journal of infectious diseases, 169(5), 1994, pp. 1159-1162
Authors:
LANG AB
FURER E
CRYZ SJ
Citation: Ab. Lang et al., FEASIBILITY OF PROPHYLAXIS AND THERAPY AGAINST GRAM-NEGATIVE INFECTIONS BY HUMAN MONOCLONAL-ANTIBODIES, FEMS immunology and medical microbiology, 7(1), 1993, pp. 9-13
Risultati:
1-8
|